Neuroma Amputation
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Prevention of PostAmputation Pain With Targeted Muscle Reinnervation
C-RFA of Residual Limb Neuroma
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
Effect of Prophylactic TMR and RPNI on Neuroma and Phantom Limb Pain
Efficacy of Acupuncture in Patients With Lower Extremity Amputation With Neuroma
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Evaluation of Ultrasonic Neuroma Size With Residual Limb Pain in Above-Knee Amputees